Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Quadrivalent Influenza Vaccine (VaxigripTetra) in Pregnant Women
2016-004763-40Phase 4Completed
- Sponsor
- Sanofi
- Start
- Mar 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4 trial of Vaxigrip in influenza (2 arms), sponsored by Sanofi. Primary endpoints: Primary immunogenicity endpoints and Primary safety endpoints. Started Mar 2017; status: completed.
02
Drugs
Vaxigrip
03
Conditions
influenza
Beyond the preview
Go deeper on 2016-004763-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004763-40.